Loading
Every trade that managers of Advaxis, Inc. disclose to SEC (Form 4) is tracked on this page. Advaxis, Inc. has had no insider filing for more than a year; the last one goes back to 1 February 2016.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
20 of 20 declarations
Advaxis, Inc. is a biopharmaceutical company that develops immunotherapy treatments for cancer. It focuses on using DNA technology to stimulate the immune system.